Guerbet

Revenue at September 30, 2020

Revenue at September 30, 2020

Activity at constant exchange rates in line with the end-2020 objectives

• • • -9.1% at constant exchange rates (CER)^* at €548.3 million
    • -11.2% at current exchange rates at €536.0 million

Gradual upturn in activity in the third quarter, particularly in Asia and Europe

Villepinte, October 22, 2020 – Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, has announced its revenue for the first nine months of its 2020 financial year.

At September 30, 2020, reported revenue was €536.0 million, an 11.2% decrease from the same period last year, including a significant negative forex impact of €12.3 million. Revenue at constant exchange rates (CER) totaled €548.3 million over the first nine months. This figure is consistent with the Group’s expectations, down 9.1%.     

Consolidated Group revenue (IFRS)

In millions of euros, at September 30, 2020	Change (%)	2020 at current exchange rates	Change (%)	2020 at constant exchange rates*	Reported 2019
Sales in Europe	-16.6%	212.7	-16.4%	213.2	255.0
Sales in Other Markets	-7.2%	323.3	-3.8%	335.1	348.5
Total	-11.2%	536.0	-9.1%	548.3	603.5

After a second quarter down 17.8% from 2019, revenue at constant exchange rates for the third quarter totaled €181.3 million, down 10.7%, reflecting an upturn in activity. The negative forex impact over the quarter was €8.9 million.

In millions of euros, July 1 to September 30, 2020	Change (%)	Q3 2020 at current exchange rates	Change (%)	Q3 2020 at constant exchange rates*	Reported Q3 2019
Sales in Europe	-6.5%	73.8	-5.7%	74.5	79.0
Sales in Other Markets	-20.5%	98.6	-13.8%	106.8	123.9
Total	-15.1%	172.4	-10.7%	181.3	202.9